JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.

Setting

Order Through VWR & Receive a FREE Sample

Support: [email protected]

Track Your Order

Home
Bioactive Compounds
Signaling Pathways

Signaling Pathways

B1614 Solifenacin succinate

Target: M3 Receptors

Summary: Muscarinic receptor antagonist

≥24.05 mg/mL
B1188 Lenalidomide hemihydrate

Summary: TNF-α secretion inhibitor

insoluble in H2O; insoluble in EtOH; ≥30.1 mg/mL
B2237 Eletriptan HBr

Summary: selective 5-HT1B and 5-HT1D receptor agonist

≥23.17 mg/mL
B1600 Darifenacin HBr

Target: M3 Receptors

Summary: Selective M3 muscarinic receptor antagonist

insoluble in EtOH; insoluble in H2O; ≥20.2 mg/mL
B1682 Bosentan

Summary: Endothelin receptor antagonist

≥26.45 mg/mL
B1521 Bosentan Hydrate

Summary: endothelin receptor antagonist

≥57.21 mg/mL
B1569 Bepotastine Besilate
1 Citation

Summary: Non-sedating, selective antagonist of histamine 1 (H1) receptor

≥15.9 mg/mL
B2229 Palonosetron HCl

Summary: 5-HT receptor antagonist

insoluble in EtOH; ≥16.6435 mg/mL
B1033 (R)-(+)-Tolterodine

Summary: Muscarinic receptor antagonists

Soluble in DMSO
B1754 Fenspiride HCl

Summary: α adrenergic and H1 histamine receptor antagonist

≥14.84 mg/mL